The European experience

Transplantation

Volumn 84, Issue 12 S SUPPL., 2007, Pages

  Tydén, Gunnar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ABO incompatible; Antigen specific; Immunoadsorption; Rituximab

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS;

ANTIGEN SPECIFICITY; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL PROTOCOL; CONFERENCE PAPER; GERMANY; GRAFT FAILURE; GREECE; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; NETHERLANDS; NORWAY; PLASMAPHERESIS; PRIORITY JOURNAL; SPAIN; SURVIVAL; SWEDEN; SWITZERLAND; UNITED KINGDOM;

ABO BLOOD-GROUP SYSTEM; ADSORPTION; ANTIBODIES, MONOCLONAL; ANTIGENS; BLOOD COMPONENT REMOVAL; BLOOD GROUP INCOMPATIBILITY; DRUG ADMINISTRATION SCHEDULE; EUROPE; HISTOCOMPATIBILITY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID;

EID: 37549035065     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000296007.08413.75     Document Type: Conference Paper

References (11)

1. 2 to O) kidney transplantation in human subjects: A clinical, serologic, and biochemical approach. Transplant Proc 1987; 19: 4528.
2. 2 kidneys into O or B recipients: The effect of pretransplant anti-A titers on graft survival. Transplant Proc 1987; 19: 4565.
3. Alexandre GPJ, Squifflet JP, De Bruyère M et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19: 4538.
4. Slapak M, Digard N, Ahmed M, Shell T, Thompson F. Renal transplantation across the ABO barrier - a 9-year experience. Transplant Proc 1990; 22: 1425.
5. Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1011.
6. Tydén G, Kumlien G, Genberg H, et al. ABO-incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5: 145.
7. Kumlien G, Ullström L, Losvall A, Persson LG, Tydén G. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006; 46: 1568.
8. Tydén G, Kumlien G, Genberg H, et al. The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy. Xenotransplantation 2006; 13: 105.
9. Nordén G, Briggs D, Cockwell P, et al. The Gothenburg/Birmingham experience of ABO-incompatible renal transplantation using carbohydrate-based immunoadsorption and anti-DC20 mAbs. Xenotransplantation 2006; 13: 148.
10. Donauer J, Wilpert J, Pisarski P, et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: The German experience. Xenotransplantation 2006; 13: 108.
11. Tydén G, Donauer J, Wadström J, et al. Implementation of a protocol for ABO-incompatible kidney transplantation - a three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153.